ABSTRACT
BACKGROUND AND PURPOSE: Vascular dementia (VAD) and dementia of the Alzheimer type (DAT) are malignant conditions of the elderly. More information is required to clarify expected lengths of survival, which condition is more lethal, and which risk factors may influence survival duration. METHODS: Cross-sectional and longitudinal designs were used. Survival interval was the period after study admission to death. From a population of 392 patients (of the 150 patients with VAD, mean age at entry was 68.3 years, of the 242 patients with DAT, mean age at entry was 73.0 years), there were 52 deaths, 26 patients with VAD and 26 patients with DAT. Pre-entry dementia symptoms were present for a mean of 3.1 years, with median follow-up of 3.6 years. Among 236 control subjects, there were 19 deaths. Entry age was 69.5 years, with median follow-up of 8.8 years. Influences of risk factors for stroke and body mass index on symptom duration, survival intervals, and cause of death were evaluated. RESULTS: Family history of neurodegenerative disorders, principally DAT, negatively influenced DAT survival. Body mass index declined with age and duration of pre-entry symptoms among men and women in all three groups. Before entry, for men, dementia symptoms were present for shorter periods compared with women. After entry, VAD and DAT patients had similar survival intervals. Causes of death were similarly distributed (78% of patients with VAD died from vascular causes, 56% of patients with DAT and 67% of the controls). CONCLUSION: VAD and DAT are malignant conditions negatively influencing survival times. Being a woman seems to play a protective role in symptom duration before diagnosis, but after diagnosis survival times of men and women were similar. We attribute equivalence of survival intervals among dementia groups to control of risk factors for cerebrovascular disease.
ABSTRACT
Migraine headaches usually decrease in frequency and severity and often cease during advancing age. Occasionally, migraineurs report late-life migrainous accompaniments, i.e., auras without headache, particularly when typical migraine attacks terminate or diminish following major or minor strokes, at which time the auras may become atypical. Clinical observations such as these suggest that degenerative cerebrovascular changes accompanying aging may modify the course of migraine headaches particularly those with aura. To test this hypothesis, we quantitated age-related changes in cerebral vasodilator capacitance by measuring local cerebral blood flow utilizing xenon contrast computed tomography (CT) scanning before and after oral administration of the pharmacological cerebral vasodilator, acetazolamide (Diamox). Measurements were compared among 27 normal volunteers without headache (aged 24-94 years; mean age 61.1 +/- 17.6) and 37 carefully categorized groups of migraine patients (aged 27-83 years; mean age 59.4 +/- 12.4). The normals comprised Group A. Migraineurs were divided into two subgroups: Group B consisted of 27 migraineurs with and without aura who continued to suffer from incapacitating and frequent headaches and Group C consisted of 10 migraineurs who no longer suffered from severe and frequent headaches, two of whom still complained of atypical auras of the "late-life migrainous accompaniments" type. Cerebral vasodilator capacitance significantly declined with advancing age among normals and the two groups of migraineurs, confirming the development of age-related cerebrovascular diseases. Global CBF increases after Diamox in Group B (with persistent and severe migraine), were significantly greater compared with normals without headache, and with Group C consisting of migraineurs whose headaches had decreased, subsided, or become replaced by late-life migrainous accompaniments (Group C). Results establish that cerebrovasodilator capacitance declines with advancing age, probably due to progressive cerebral atherosclerosis, since these declines were accentuated by risk factors for stroke, particularly TIAs or documented lacunar infarcts by CT. Progressive impairments of cerebral vasodilator capacitance among migraineurs were associated with: (i) reductions in frequency and severity of migrainous cephalalgia and (ii) appearance of late-life migrainous accompaniments.
Subject(s)
Cerebrovascular Disorders/physiopathology , Migraine Disorders/physiopathology , Adult , Age Factors , Aged , Aged, 80 and over , Blood Flow Velocity/physiology , Brain/blood supply , Cerebral Infarction/diagnosis , Cerebral Infarction/physiopathology , Cerebrovascular Disorders/diagnosis , Female , Humans , Intracranial Arteriosclerosis/diagnosis , Intracranial Arteriosclerosis/physiopathology , Ischemic Attack, Transient/diagnosis , Ischemic Attack, Transient/physiopathology , Male , Middle Aged , Migraine Disorders/diagnosis , Pain Measurement , Tomography, X-Ray Computed , Vasodilation/physiologyABSTRACT
It is concluded that the most important determinants for cerebral neurodegenerative changes and cognitive decline during aging are neuronal shrinkage and/or loss, which are accelerated by certain risk factors: e.g. TIAs, hypertension, heart disease, hyperlipidemia, smoking, heavy alcohol consumption, male gender, low educational status, family history of cerebrovascular disease and absence of estrogen replacement therapy among women. Some of these risk factors are remediable by therapeutic interventions, including prevention of TIAs and medications that control hypertension, heart disease, hyperlipidemia and estrogen replacement in postmenopausal women, as well as abstention from abuse of tobacco and alcohol. Cerebral neurodegenerative changes measured by neuroimaging appear to be premorbid markers for depleted neuronal and synaptic reserves which predispose to the onset of dementias of both VAD and DAT types. Normal subjects at risk for cognitive decline include those with TIAs, hypertension and heart disease since these risk factors measurably accelerate cerebral atrophy, ventricular enlargement, leukoaraiosis, and decline in cortical perfusion.
Subject(s)
Atrophy/pathology , Brain/pathology , Dementia/pathology , Nerve Degeneration/physiopathology , Adult , Aged , Aged, 80 and over , Analysis of Variance , Case-Control Studies , Cerebrovascular Circulation/physiology , Cognition Disorders/diagnosis , Cross-Sectional Studies , Female , Humans , Longitudinal Studies , Male , Middle Aged , Regression Analysis , Risk Factors , Tomography, X-Ray ComputedABSTRACT
Factors that accelerate rates of 'normal' age-related cerebral atrophic and degenerative changes are important because they may predispose to cognitive declines. To determine characteristic patterns of normal aging, risk factors were correlated with serial neurological-neuropsychological examinations, CT measures of progressive cerebral atrophy, local tissue hypodensities, or perfusional declines. Both cross-sectional and longitudinal designs were utilized. Ninety-four cognitively and neurologically normal aging volunteers, 15 with a history of transient ischemic attacks (TIAs), were followed for mean intervals of 3.0+/-2.1 years. Results indicated that: (1) after age 60, cerebral atrophy, polio- and leuko-araiosis doubled and cerebral perfusion decreased, with marked individual variations; (2) risk factors independently accelerating cerebral atrophy and cortico-subcortical perfusional declines included TIAs, hypertension, smoking, hyperlipidemia, excessive alcohol consumption and male gender; (3) progressive leuko-araiosis correlated directly with cortical atrophy and cortical perfusional declines. We posit that: (1) cerebral atrophy and degenerative changes result from neuronal shrinkage and/or loss, which are accelerated by TIAs, hypertension, smoking, hyperlipidemia, excessive alcohol consumption and male gender; (2) accelerated cerebral atrophic and degenerative changes identified by neuroimaging should be considered as markers for depleted neuronal synaptic reserves, which predispose to cognitive declines. Interventions available for controlling some of these risk factors include control of TIAs, hypertension, and hyperlipidemia, as well as tobacco and alcohol withdrawal.
Subject(s)
Aging/pathology , Cerebral Cortex/pathology , Cognition Disorders/epidemiology , Cognition Disorders/pathology , Adult , Aged , Aged, 80 and over , Apoptosis , Atrophy , Cross-Sectional Studies , Female , Humans , Hyperlipidemias/epidemiology , Longitudinal Studies , Male , Middle Aged , Risk FactorsSubject(s)
Aging/pathology , Brain/pathology , Aged , Aged, 80 and over , Atrophy , Cerebrovascular Circulation , Female , Humans , Male , Middle Aged , Neuropsychological Tests , Risk FactorsABSTRACT
Vascular dementia (VAD) is considered to be the second most common cause of dementia in Europe and the US. In Asia and many developing countries, it is more common than dementia of the Alzheimer's type (DAT). VAD is the most preventable form of dementia associated with later life. The pathogenesis of VAD is multifactorial, and it represents a heterogeneous, not a homogeneous, clinical entity. Classification of VAD by pathogenesis is important for its prevention and treatment. Control of the risk factors for VAD reduces its incidence and stabilises or improves cognitive performance following stroke. Proper diagnostic evaluation of VAD requires: (i) a well defined quantitative assessment of the cognitive deficits present; (ii) assessment of risk factors for stroke; (iii) identification of cerebral vascular lesions by history, neurological examination and neuroimaging; (iv) exclusion of other causes of dementia; (v) establishment of a positive diagnosis of possible, probable or definite VAD versus DAT or mixed VAD/DAT; and (vi) identification of the temporal relationship between cognitive deficits and cerebral vascular lesions. VAD can be subdivided into 8 major types, as follows: (i) multi-infarct dementia secondary to large cerebral emboli [type 1]; (ii) strategically placed infarctions causing dementia [type 2]; (iii) multiple subcortical lacunar lesions secondary to atherosclerosis or degenerative arteriolar changes [type 3]; (iv) Binswanger's disease (arteriosclerotic subcortical leukoencephalopathy) [type 4]; (v) mixtures of types 1, 2 and 3 [type 5]; (vi) haemorrhagic lesions causing dementia [type 6]; (vii) subcortical dementia secondary to hereditary factors (type 7); and (viii) mixtures of DAT and VAD (type 8). Treatment is dictated by the pathogenetic subtype of VAD that is present.
Subject(s)
Dementia, Vascular , Dementia, Vascular/classification , Dementia, Vascular/diagnosis , Dementia, Vascular/etiology , Dementia, Vascular/therapy , Humans , Risk FactorsSubject(s)
Alzheimer Disease/drug therapy , Estrogen Replacement Therapy , Aged , Alzheimer Disease/etiology , Alzheimer Disease/physiopathology , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Cerebrovascular Circulation , Cholesterol/blood , Female , Humans , Hypertension/complications , Middle Aged , Risk Factors , Vitamins/therapeutic useABSTRACT
The ability to utilize color information was investigated in 12 patients with mild to moderate probable Alzheimer's Disease (DAT) and in 12 age- and gender-matched control subjects. All subjects underwent testing of visual acuity and color vision before being tested with a cognitive task consisting of four conditions (no color, color as attention enhancer, color as valid cue, color as distracter). Although the groups did not differ in visual acuity or color vision, patients with DAT were less accurate than controls in all four conditions of the cognitive task. Both groups performed best with color as a valid cue and worst with color as distracter, but condition had a significantly stronger effect on patients than on controls. It is concluded that color is a potent stimulus attribute for patients with DAT.
ABSTRACT
Cerebrovascular capacitance was tested by measuring local cerebral blood flow (LCBF) by xenon-contrasted CT scanning before and after the oral administration of 14.3 mg/kg of acetazolamide among 45 subjects including 15 age-matched controls without history of headache, 20 migraineurs with and without aura, 3 patients with cluster headache, and 7 patients with tension-type headache. Percentage increases of LCBF were measured in 10 regions located throughout both hemispheres. Laterality indices for asymmetric LCBF increases were calculated. Local cerebral blood flow in cortical gray matter increased 5.9% in controls, 9.9% in patients with tension headaches, but 18.6% in both migraine and cluster headache patients; significantly greater LCBF increases than among controls or among patients with tension headaches (P < 0.05). Increases in LCBF were significantly asymmetric among migraine and cluster patients and provoked typical unilateral vascular headaches which responded to sumatriptan. Maximal asymmetric LCBF increases also corresponded to the reported side of the induced headaches confirming their vascular pathogenesis. Patients with tension headaches and controls without history of headache did not develop head pain after acetazolamide.
Subject(s)
Acetazolamide , Cerebrovascular Circulation , Cluster Headache/physiopathology , Migraine Disorders/physiopathology , Tension-Type Headache/physiopathology , Vasodilator Agents , Acetazolamide/pharmacology , Adult , Aged , Cerebrovascular Circulation/drug effects , Cluster Headache/chemically induced , Cluster Headache/diagnosis , Diagnosis, Differential , Female , Humans , Male , Middle Aged , Migraine Disorders/chemically induced , Migraine Disorders/diagnosis , Tension-Type Headache/diagnosis , Vasodilator Agents/pharmacologyABSTRACT
A prospective case-control study was carried out to clarify associations of cerebral transient ischemic attacks (TIAs) and other stroke risk factors with progression and exacerbation of cardiovascular and cerebrovascular disorders; 243 neurologically normal controls and 123 TIA patients without prior history of stroke were followed up for a mean interval of 4.4 years of TIA patients, 26 (21%) developed other events (excluding recurrent TIAs); 10 died of vascular causes (8.1%). Of controls, 44 (18%) developed events; 13 died of vascular causes (5.4%) and 3 from cancer. TIA patients were at 2.3 times greater risk than normal controls for stroke or death from vascular causes. They were predominantly male with significantly higher associations of risk factors for stroke, including hypertension, heart disease, diabetes mellitus, smoking, hyperlipidemia, alcohol consumption, and limited education. Controls developing vascular events compared with controls who did not were older, more frequently male, and with greater incidences of heart disease. TIA patients had lower rates of cerebral perfusion compared with controls that persisted throughout the study, with similar rates of decline related to aging among both groups. Among TIA patients, stroke risk factors were more prevalent than among controls. The longer their duration, the greater the incidence and the more rapid the rate of severe, often fatal cardiovascular complications.
Subject(s)
Cerebrovascular Circulation , Ischemic Attack, Transient/complications , Age Factors , Aged , Alcohol Drinking/adverse effects , Case-Control Studies , Cerebrovascular Disorders/etiology , Cerebrovascular Disorders/physiopathology , Diabetes Complications , Disease Progression , Educational Status , Female , Follow-Up Studies , Humans , Hyperlipidemias/complications , Hypertension/complications , Incidence , Ischemic Attack, Transient/physiopathology , Logistic Models , Male , Middle Aged , Prevalence , Prospective Studies , Recurrence , Risk Factors , Sex Factors , Smoking/adverse effects , Survival RateABSTRACT
Computerized tomographic measures of recurrent cerebral infarctions, atrophy and local perfusion were all prospectively correlated with cognitive testing during treatment of risk factors plus antiplatelet therapy among vascular dementia patients. Neurological and cognitive status were quantified among 22 demented patients with small strokes and compared with 22 age-matched normal volunteers. In vascular dementia, risk factor control plus antiplatelet therapy reduced cerebral infarctions, increased perfusion, and stabilized or improved cognitive test performance, despite age-related, progressive cerebral atrophy.
Subject(s)
Brain Ischemia/psychology , Brain/pathology , Cerebrovascular Disorders/pathology , Cerebrovascular Disorders/psychology , Cognition/physiology , Aged , Aged, 80 and over , Atrophy/pathology , Atrophy/psychology , Blood Pressure/physiology , Cerebral Infarction/pathology , Cerebral Infarction/psychology , Dementia, Vascular/physiopathology , Dementia, Vascular/psychology , Female , Humans , Male , Middle Aged , Psychiatric Status Rating Scales , Risk Factors , Tomography, X-Ray ComputedSubject(s)
Brain/diagnostic imaging , Tomography, X-Ray Computed , Brain/blood supply , Humans , Regional Blood Flow , XenonABSTRACT
This investigation was designed to clarify the chronic effects of cardiogenic emboli on cerebral perfusion and tissue densities within remaining noninfarcted brain. Local cerebral perfusion and tissue densities were measured by xenon-contrasted CT scanning and compared by cross-sectional designs among normal volunteers without heart disease (Group C, n = 44), normal volunteers with heart disease (Group N, n = 20), patients with heart disease and lacunar infarctions (Group L, n = 31) and patients with heart disease associated with cardiogenic cerebral embolism (Group E, n = 12). In Group E, remaining cortical and subcortical gray and white matter perfusion were reduced compared to Groups C and N (p = 0.01), but did not differ from Group L, who had similar profiles of risk factor for stroke. In Group E, perfusion was reduced within the thalamus ipsilateral to cortical infarctions (p < 0.05). There were no differences in remaining tissue densities between Groups E and L. It is concluded that reduced cerebral perfusion in noninfarcted regions among patients with cardiogenic emboli appears to be related to atherosclerosis of small cerebral vessels in a similar manner to patients with lacunes, but thalamo-cortical disconnections also contribute to cerebral hypoperfusion.
Subject(s)
Brain/blood supply , Cerebrovascular Disorders/complications , Heart Diseases/complications , Adult , Age Factors , Aged , Aged, 80 and over , Blood Pressure , Brain/pathology , Carbon Dioxide/blood , Cerebral Infarction/pathology , Cerebrovascular Circulation/physiology , Cerebrovascular Disorders/diagnostic imaging , Cerebrovascular Disorders/etiology , Electrocardiography , Electroencephalography , Embolism/etiology , Embolism/physiopathology , Female , Humans , Male , Middle Aged , Regional Blood Flow/physiology , Risk Factors , Sex Factors , Tomography, X-Ray ComputedABSTRACT
BACKGROUND AND PURPOSE: Cognitive test performances were correlated prospectively with changes in cerebral CT measurements of atrophy, infarct volume, ventricular enlargement, local tissue density, and local perfusion to contrast annual rates of changes among patients with ischemic vascular dementia (IVD) or dementia of the Alzheimer type (DAT). METHODS: The cerebral atrophic index (ATI; ratio of cerebrospinal fluid or infarcted brain to intracranial volume), infarct volume ratio, ventricular volume ratio (VVR; ventricular volume/intracranial volume), cortical and subcortical gray and white matter local perfusion (local cerebral blood flow [LCBF]), and local Hounsfield unit (HU) density were measured concurrently and compared longitudinally with Cognitive Capacity Screening Examinations (CCSE) scores among 24 treated IVD (age, 68.2 +/- 9.7 years; follow-up, 42 +/- 27 months) and 24 DAT patients (age, 74.2 +/- 6.2 years; follow-up, 30 +/- 19 months). RESULTS: IVD annual changes were as follows: CCSE, +1.2 +/- 5.9; ATI, +2.1%/y; VVR, +3.2%/y; and LCBF in the subcortical basal ganglia, -0.74 mL.100 g-1.min-1.y-1 (-1.8%/y). DAT annual changes were as follows: CCSE, -1.8/y; ATI, +8.1%/y; VVR, +9.6%/y; cortical LCBF, -2.0 mL.100 g-1.min-1.y-1 (-5.2%/y); LCBF in the basal ganglia, -3.0 mL.100 g-1.min-1.y-1 (-6.7%/y); white matter LCBF, -0.75 mL.100 g-1.min-1.y-1 (-4.1%/y); and all cortical tissue densities, -0.83 HU/y (-2.1%/y). In IVD, multiple regression analyses correlated cognitive changes directly with (1) recurrent silent infarctions and (2) bidirectional changes of perfusions within frontal white matter, thalamus, and internal capsules. In DAT, cognitive declines correlated with cerebral atrophy and cortical hypoperfusion related to frontotemporal and parietal cortical polioaraiosis (decreased gray matter tissue densities). CONCLUSIONS: In IVD, recurrent strokes were not observed clinically during risk factor control, and antiplatelet therapy and cognitive impairments improved or stabilized. In DAT, cognitive performance relentlessly declined. Ischemic pathogenesis for vascular dementia is supported by the following: (1) cognitive declines correlate directly with recurrent "silent" strokes, and (2) bidirectional cognitive changes correlate directly with frontal white matter, thalamic, and internal capsular perfusional changes.
Subject(s)
Alzheimer Disease/diagnostic imaging , Brain/diagnostic imaging , Dementia, Vascular/diagnostic imaging , Tomography, X-Ray Computed , Aged , Aged, 80 and over , Alzheimer Disease/physiopathology , Brain/blood supply , Cognition , Dementia, Vascular/physiopathology , Female , Humans , Male , Microcirculation , Middle Aged , Prospective StudiesABSTRACT
Estrogen replacement therapy (ERT) and associated risks for ischemic vascular dementia (IVD) and dementia of the Alzheimer's type (DAT) among postmenopausal women were investigated by determining whether ERT was differently distributed among control subjects than among subjects with dementia. Subjects included 93 with probable DAT, 65 with probable IVD, and 148 normal control subjects. The proportion of control subjects on ERT was almost 2:1, and this ratio holds for both dementia groups. Logistic regression suggests lack of ERT is associated with increased risk for dementia among elderly women. ERT may eventually prove to be a useful prophylactic agent for reducing risk of DAT and IVD among postmenopausal women.
Subject(s)
Dementia/epidemiology , Estrogen Replacement Therapy , Aged , Alzheimer Disease/epidemiology , Alzheimer Disease/prevention & control , Alzheimer Disease/psychology , Dementia/psychology , Dementia, Vascular/epidemiology , Dementia, Vascular/prevention & control , Dementia, Vascular/psychology , Female , Humans , Middle Aged , Psychiatric Status Rating Scales , Risk FactorsABSTRACT
Education and occupation as sociodemographic risk factors for dementias of the Alzheimer (DAT) and ischemic vascular types (IVD) were evaluated by two case series studies. Cases were compared to well-evaluated individuals identified as healthy normals acting as controls. There were 150 patients with probable DAT, 102 patients with probable IVD, and 188 neurologically and cognitively normal subjects. Logistic regression indicated that for DAT, education with occupation was the best predictor (OR, 1.51; 95% CI, 1.23-1.87). For IVD, the two predictors were: education with occupation (OR, 1.84; 95% CI 1.38-4.50) and education with gender (OR, 3.40; 95% CI, 1.29-8.92). We conclude that risk of dementia is increased in those with limited educational background and occupational achievement.
Subject(s)
Alzheimer Disease/epidemiology , Dementia, Vascular/epidemiology , Educational Status , Occupations , Achievement , Aged , Alzheimer Disease/diagnosis , Dementia, Vascular/diagnosis , Female , Functional Laterality , Humans , Logistic Models , Male , Middle Aged , Probability , Risk Factors , Sex FactorsABSTRACT
Cerebral CT changes are correlated with cognitive declines among 18 patients with probable dementia of Alzheimer type (DAT) (7 men, 11 women, mean age 75.4 years) and are compared for control purposes with similar measures among 18 age-matched normal volunteers (8 men, 10 women, mean age 73.7 years). Mean follow-up intervals are 28.6 months for DAT and 27.0 months for controls. For DAT, annual rates for ventricular volume enlargement are +9.2% and for cortical atrophy are -2.1%. Annual reductions in regional cerebral perfusions per 100 g brain/min, are: total cortex -1.1 ml, frontal -1.2 ml, temporal and parietal -0.9 ml, basal ganglia -1.6 ml, thalamus -2.5 ml, total white matter -0.6 ml, frontal white matter -0.7 ml. At entry evaluation, compared to normals, DAT patients had reduced CT densities in white matter, but not in cortex. Nevertheless, cortical CT densities declined progressively at annual rates of -0.72 Hounsfield units (HU), but remained constant in white matter. Annual point score declines for Cognitive Capacity Screening Examinations were -2.0 and for Mini Mental State: -2.8. Controls showed no cognitive change. Multiple regression analyses correlate cognitive declines with: (1) reductions in perfusion within parietal cortex (p = 0.015), (2) decreases in cortical volume (p = 0.019), and (3) decreases in HU within subcortical gray matter (p = 0.007).
Subject(s)
Alzheimer Disease/pathology , Alzheimer Disease/psychology , Brain/pathology , Cerebrovascular Circulation , Cognition Disorders/etiology , Aged , Aged, 80 and over , Brain/blood supply , Brain/diagnostic imaging , Female , Follow-Up Studies , Humans , Male , Middle Aged , Neuropsychological Tests , Severity of Illness Index , Tomography, X-Ray ComputedABSTRACT
To compare longitudinal changes of cerebral perfusion (CBF) and cognitive status in two common forms of dementia in the elderly, 42 patients with ischemic vascular dementia (IVD), 44 patients with dementia of the Alzheimer type (DAT), and 120 elderly normal volunteers were evaluated prospectively over a mean interval of 3.35 years. Subjects were at least age sixty, (mean age 71.1). Mean bihemispheric cerebral blood flow and cognitive test scores of control subjects were significantly higher than those of both demented groups at entry and remained so. After adjustment for initial CBF, course over time was similar for all groups. Group variability was similar for CBF but not for cognition. Both IVD and DAT patients were more variable than controls but similar to each other. Throughout, DAT patients showed greater cognitive impairments than IVD patients. Cognitive impairments stabilized among IVD patients treated by control of risk factors, antiplatelet or anticoagulant therapy but declined progressively among DAT patients.
Subject(s)
Alzheimer Disease/physiopathology , Brain Ischemia/complications , Cerebrovascular Circulation , Cognition Disorders/etiology , Dementia, Vascular/physiopathology , Age Factors , Aged , Aged, 80 and over , Alzheimer Disease/complications , Alzheimer Disease/psychology , Cerebral Cortex/blood supply , Cognition Disorders/diagnosis , Dementia, Vascular/etiology , Dementia, Vascular/psychology , Female , Follow-Up Studies , Heart Diseases/complications , Heart Diseases/epidemiology , Humans , Hypertension/complications , Hypertension/epidemiology , Incidence , Male , Middle Aged , Prospective Studies , Psychological Tests , Regional Blood Flow , Regression Analysis , Risk Factors , Time FactorsABSTRACT
41 patients (30 men, 11 women, mean age 65.3 +/- 9.7 years) with probable ischemic vascular dementia diagnosed according to stated clinical criteria at least 3 months after hospital discharge and among a few nonhospitalized subjects with thorough clinical, neurovascular and neuroimaging workup have been followed for the past 7 years with serial measures of neurological and cognitive status and cerebral blood flow using stable xenon-enhanced CT. Cognitive impairments correlated with cerebral ischemia rather than CT measurements of infarcted brain volume. A minimum of one follow-up was required and follow-up intervals ranged from 4 months to 6.6 years (mean 3.4 +/- 1.6 years). 9 patients (22.0%) were lost to follow-up, 4.9% died, 9.8% became incapacitated by additional strokes, 2.4% by cancer and 4.9% moved away. Cross-sequential designs adjust for problems of attrition. Mortality rates of 1.4%/year during 1986-1993 are significantly lower than 2.0%/year between 1983 and 1986. Declines in mortality are attributed to control of risk factors and antiplatelet treatment of atherosclerotic cerebral vascular disease and anticoagulant treatment of patients with cardiogenic embolism.
Subject(s)
Databases, Factual/statistics & numerical data , Dementia, Vascular/epidemiology , Neurologic Examination/statistics & numerical data , Neuropsychological Tests/statistics & numerical data , Tomography, X-Ray Computed/statistics & numerical data , Aged , Brain/blood supply , Dementia, Vascular/diagnosis , Dementia, Vascular/mortality , Female , Follow-Up Studies , Humans , Male , Middle Aged , Psychometrics , Regional Blood Flow/physiology , Survival RateABSTRACT
The hypothesis was tested among 83 patients with multiple lacunar infarctions that cerebral hypoperfusion will correlate with cognitive impairments. Patients were subdivided according to Cognitive Capacity Screening Examination (CCSE) scores into a cognitively impaired group (Group D, n = 40; mean age, 68.2 years) with CCSE scores between 6 and 25 (mean, 19.9) and a cognitively intact group (Group I, n = 43; mean age, 66.0) with normal scores (mean, 29.4). Gray and white matter tissue densities were measured by plain computed tomography (CT), and their compartmental perfusions were estimated during stable xenon inhalation. Eighty infarcts in basal ganglia and white matter were detected in Group D and 62 in Group I. Cognitive impairments correlated with (a) multiplicity and bilaterality of lacunes; (b) hypertension, diabetes mellitus, and multiplicity of risk factors for stroke; (c) hypoperfusion of white and gray matter, but particularly of frontal white matter; (d) leuko-araiosis; (e) aging; and (f) lower education. The conclusion was that hypertension and diabetes mellitus are potent risk factors for cerebral small vessel disease or arteriolosclerosis ultimately resulting in lacunar infarcts, leuko-araiosis, white matter hypoperfusion, and impaired cognitive test performance.